Get the Stockscreener App
0.00
100.00%
-0.355
Turnstone Biologics Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
See More
Previous Close:
$0.355
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$8.21M
Revenue:
$81.89M
Net Income/Loss:
$-55.20M
P/E Ratio:
0.00
EPS:
-2.6959
Net Cash Flow:
$-67.40M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.8462
Turnstone Biologics Corp Stock (TSBX) Company Profile
Name
Turnstone Biologics Corp
Sector
Industry
Phone
347-897-5988
Address
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
Compare TSBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TSBX
Turnstone Biologics Corp
|
0.00 | 8.21M | 81.89M | -55.20M | -67.40M | -2.6959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-14-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-16-23 | Initiated | SVB Securities | Market Perform |
| Aug-15-23 | Initiated | BofA Securities | Buy |
| Aug-15-23 | Initiated | Piper Sandler | Overweight |
View All
Turnstone Biologics Corp Stock (TSBX) Latest News
Using Bollinger Bands to evaluate Turnstone Biologics Corp.Weekly Trend Recap & Daily Oversold Bounce Ideas - Newser
What makes Turnstone Biologics Corp. stock price move sharplyMarket Performance Summary & Verified Technical Signals - Newser
Xoma Completes Merger with Turnstone Biologics Corp - TipRanks
Is Turnstone Biologics Corp. a candidate for recovery playQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Sectors Driving Future Growth for Turnstone Biologics Corp. StockProduct Launch & Verified High Yield Trade Plans - Newser
How to read the order book for Turnstone Biologics Corp.July 2025 Big Picture & Community Consensus Trade Signals - Newser
How to integrate Turnstone Biologics Corp. into portfolio analysis toolsQuarterly Profit Report & Reliable Intraday Trade Alerts - Newser
What the charts say about Turnstone Biologics Corp. todayJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Live market analysis of Turnstone Biologics Corp.July 2025 Market Mood & Risk Managed Investment Strategies - Newser
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements - Yahoo Finance
Volatility clustering patterns for Turnstone Biologics Corp.July 2025 Review & Capital Efficiency Focused Strategies - Newser
Intraday pattern recognizer results for Turnstone Biologics Corp.July 2025 Opening Moves & Weekly High Return Stock Forecasts - Newser
Lava Therapeutics shares rise 1.32% intraday after XOMA Royalty Corporation's acquisition of Turnstone Biologics Corp. - AInvest
Can volume confirm reversal in Turnstone Biologics Corp.July 2025 Chart Watch & Daily Profit Maximizing Trade Tips - Newser
Is Turnstone Biologics Corp. Stock Overbought or Oversold RSI Indicator AnalysisGrowth Projection Summary for Long-Term Investors - Newser
Will Turnstone Biologics Corp. rebound enough to break evenIntraday Price Forecast Using Volume Models - Newser
Turnstone Biologics Updates Corporate Governance Structure - TipRanks
XOMA Royalty Corporation completed the acquisition of Turnstone Biologics Corp.. - MarketScreener
XOMA Royalty Completes Tender Offer for Turnstone Biologics - MarketScreener
Xoma closes tender offer for Turnstone Biologics - TipRanks
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics - GlobeNewswire
Visual trend scoring systems applied to Turnstone Biologics Corp.Free Buy Low Sell High Stock Watch - Newser
Turnstone Biologics Corp. stock momentum explainedFree Technical Entry Strategy for Beginners - Newser
Tick level data insight on Turnstone Biologics Corp. volatilityFree Step-by-Step Stock Investment Guide - Newser
Turnstone Biologics Corp.’s volatility index tracking explainedFree Fundamental Growth Stock Analysis - Newser
How Efficient Is Turnstone Biologics Corp. at Controlling Operating CostsFree Multi-Bagger Potential Stock Forecast Tools - Newser
Turnstone Biologics Corp. SEC 10-Q Report - TradingView
turnstone biologics corp. stock momentum explained3-Day Market Movement Forecast Analysis - Newser
Is Turnstone Biologics Corp. meeting your algorithmic filter criteriaBreakout Watcher with Entry and Exit Alerts - Newser
What candlestick patterns are forming on Turnstone Biologics Corp.Entry Timing Tracker with Alert Accuracy - Newser
Turnstone Biologics Corp. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Conservative Entry for High Return Setup - Newser
Is Turnstone Biologics Corp. stock overvalued or undervaluedHigh-margin investment plays - Jammu Links News
Is Turnstone Biologics Corp. a good long term investmentExceptional profit velocity - Jammu Links News
Turnstone Biologics Corp Stock (TSBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):